AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1394026 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 55
Study 1394026 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 3903822 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen (E)
Number of subjects: 0
Study 3903822 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen (A)
Number of subjects: 0
Study 3903822 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined estrogen-androgen preparation (E-A)
Number of subjects: 0
Study 3903822 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 0
Study 3903822 — intervention group
Group type: COMPARATOR
Intervention: Hysterectomized control group with intact ovaries (CON)
Number of subjects: 0
Study 30324626 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade
Number of subjects: 56
Study 30324626 — intervention group
Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade
Number of subjects: 56
Study 27893473 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent Training (CT)
Number of subjects: 60
Study 27893473 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 60
Study 25876736 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback on progress in mental health symptoms and functioning every 6 months
Number of subjects: 257
Study 25876736 — intervention group
Group type: COMPARATOR
Intervention: Feedback on progress in mental health symptoms and functioning as soon as data were entered
Number of subjects: 257
Study 25876736 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback intervention implementation
Number of subjects: 257
Study 25318784 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive gait training with rhythmic auditory stimulation
Number of subjects: 20
Study 25318784 — intervention group
Group type: COMPARATOR
Intervention: Intensive gait training (control group)
Number of subjects: 20
Study 22770377 — intervention group
Group type: EXPERIMENTAL
Intervention: Salidroside (600 mg/day)
Number of subjects: 60
Study 22770377 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 20581169 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib 200 mg orally once daily (increased to 400 mg if well tolerated)
Number of subjects: 59
Study 20581169 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 20581169 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 59
Study 18076223 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 7
Study 18076223 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive static stretching
Number of subjects: 7
Study 18076223 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic stretching
Number of subjects: 7
Study 18076223 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 7
Study 15129736 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol pretreatment
Number of subjects: 25
Study 15129736 — intervention group
Group type: COMPARATOR
Intervention: Control group (no allopurinol)
Number of subjects: 25
Study 11419566 — intervention group
Group type: EXPERIMENTAL
Intervention: Metrifonate (30 to 60 mg by weight or a 50-mg fixed dose once daily)
Number of subjects: 672
Study 11419566 — intervention group
Group type: EXPERIMENTAL
Intervention: Metrifonate
Number of subjects: 672
Study 11419566 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 672
Study 9521401 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (Fragmin) 5,000 U once daily
Number of subjects: 566
Study 9521401 — intervention group
Group type: COMPARATOR
Intervention: Sodium heparin 5,000 U twice daily
Number of subjects: 566
Study 9521401 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (Fragmin)
Number of subjects: 566
Study 9521401 — intervention group
Group type: COMPARATOR
Intervention: Sodium heparin
Number of subjects: 566
Study 7721127 — intervention group
Group type: EXPERIMENTAL
Intervention: Labor conditions
Number of subjects: 0
Study 7721127 — intervention group
Group type: COMPARATOR
Intervention: Profession, length of service, age
Number of subjects: 0
Study 2685951 — intervention group
Group type: EXPERIMENTAL
Intervention: Uniphyllin (UP) taken as a single dose at bedtime
Number of subjects: 59
Study 2685951 — intervention group
Group type: COMPARATOR
Intervention: Slophyllin (SP) taken twice daily
Number of subjects: 59
Study 789170 — intervention group
Group type: EXPERIMENTAL
Intervention: N‐acetyl‐L‐glutamine aluminum complex (KW)
Number of subjects: 302
Study 789170 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic aluminum sucrose sulfate (UL)
Number of subjects: 302
Study 789170 — intervention group
Group type: COMPARATOR
Intervention: Inactive placebo of lactose (PL)
Number of subjects: 302
Study 30935243 — intervention group
Group type: EXPERIMENTAL
Intervention: Workshop intervention on responsible reporting on suicide (RRS)
Number of subjects: 26
Study 29392459 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored therapy plan and additional home visits (Intervention Group)
Number of subjects: 300
Study 29392459 — intervention group
Group type: COMPARATOR
Intervention: Standard German neurological treatment (Control Group)
Number of subjects: 300
Study 24851039 — intervention group
Group type: EXPERIMENTAL
Intervention: Spasmofen rectal suppository (100 mg ketoprofen and 10 mg hyoscine butylbromide)
Number of subjects: 80
Study 24851039 — intervention group
Group type: COMPARATOR
Intervention: Ketorolac IV (30 mg/2 mL)
Number of subjects: 80
Study 24851039 — intervention group
Group type: EXPERIMENTAL
Intervention: Spasmofen rectal suppository
Number of subjects: 80
Study 24851039 — intervention group
Group type: COMPARATOR
Intervention: Ketorolac IV
Number of subjects: 80
Study 22935440 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein low-carbohydrate (HPLC)
Number of subjects: 132
Study 22935440 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein normal-carbohydrate (HPNC)
Number of subjects: 132
Study 22935440 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal-protein low-carbohydrate (NPLC)
Number of subjects: 132
Study 22935440 — intervention group
Group type: COMPARATOR
Intervention: Normal-protein normal-carbohydrate (NPNC)
Number of subjects: 132
Study 22935440 — intervention group
Group type: COMPARATOR
Intervention: Normal-carbohydrate (NC)
Number of subjects: 132
Study 22935440 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate (LC)
Number of subjects: 132
Study 22935440 — intervention group
Group type: COMPARATOR
Intervention: Normal-protein low-carbohydrate (NPLC) vs Normal-protein normal-carbohydrate (NPNC)
Number of subjects: 132
Study 22935440 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein diets vs Normal-protein diets
Number of subjects: 132
Study 22935440 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein diets vs Low-carbohydrate diets
Number of subjects: 132
Study 21154308 — intervention group
Group type: EXPERIMENTAL
Intervention: Tc-99m-MIBI
Number of subjects: 50
Study 21154308 — intervention group
Group type: COMPARATOR
Intervention: Tc-99m-antimony sulphide colloid
Number of subjects: 50
Study 17669866 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadence Contrast Pulse Sequencing ultrasound technique with Sono Vue
Number of subjects: 30
Study 17669866 — intervention group
Group type: COMPARATOR
Intervention: Triphasic helical CT-scan
Number of subjects: 30
Study 17669866 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ultrasound and CT
Number of subjects: 30
Study 16256897 — intervention group
Group type: EXPERIMENTAL
Intervention: Psycho-educational intervention plus standard home-based palliative care (n = 54)
Number of subjects: 106
Study 16256897 — intervention group
Group type: COMPARATOR
Intervention: Standard home-based palliative care (n = 52)
Number of subjects: 106
Study 12166881 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-threshold inspiratory muscle training
Number of subjects: 16
Study 10890237 — intervention group
Group type: EXPERIMENTAL
Intervention: Total amount of therapeutic interventions measured by the TISS‐28 score
Number of subjects: 0
Study 8819179 — intervention group
Group type: EXPERIMENTAL
Intervention: BAY u 3405
Number of subjects: 23
Study 8819179 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐1452
Number of subjects: 23
Study 8819179 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 2023538 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridostigmine (PD), 120 mg administered orally
Number of subjects: 6
Study 2023538 — intervention group
Group type: COMPARATOR
Intervention: Placebo, two tablets administered orally
Number of subjects: 6
Study 2023538 — intervention group
Group type: COMPARATOR
Intervention: Saline, 1 mL injected as an IV bolus
Number of subjects: 6
Study 6266897 — intervention group
Group type: EXPERIMENTAL
Intervention: pivmecillinam/pivampicillin (pivmecillinam 200 mg plus pivampicillin 250 mg) three times daily (14 patients)
Number of subjects: 26
Study 6266897 — intervention group
Group type: COMPARATOR
Intervention: pivmecillinam alone (400 mg three times daily) (12 patients)
Number of subjects: 26
Study 31253621 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiation (NACRT)
Number of subjects: 314
Study 31253621 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy (NACT) alone
Number of subjects: 314
Study 27830281 — intervention group
Group type: EXPERIMENTAL
Intervention: Information brochure and website
Number of subjects: 332
Study 25851766 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-general anesthesia (non-GA)
Number of subjects: 348
Study 25851766 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 348
Study 25116461 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Analysis System of Psychotherapy (CBASP)
Number of subjects: 139
Study 25116461 — intervention group
Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 139
Study 22819061 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation group (standardized, three‐stage rehabilitation program)
Number of subjects: 364
Study 22819061 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard hospital ward, internal medical intervention)
Number of subjects: 364
Study 21046699 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-based hand sanitizer
Number of subjects: 476
Study 21046699 — intervention group
Group type: COMPARATOR
Intervention: Control group (no sanitizer)
Number of subjects: 476
Study 17704088 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation (SIM)
Number of subjects: 84
Study 17704088 — intervention group
Group type: COMPARATOR
Intervention: Questionnaires (QUES)
Number of subjects: 84
Study 16302598 — intervention group
Group type: EXPERIMENTAL
Intervention: Enameloplasty Sealant Technique (EST) using Tetric Flow resin
Number of subjects: 40
Study 16302598 — intervention group
Group type: COMPARATOR
Intervention: Conventional Sealant Technique (CST) using Tetric Flow resin
Number of subjects: 40
Study 12000235 — intervention group
Group type: EXPERIMENTAL
Intervention: Active group intervention designed to enhance risk perception and increase knowledge about HIV testing
Number of subjects: 398
Study 12000235 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 398
Study 9706932 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acetaminophen (1 g every 4 h)
Number of subjects: 61
Study 9706932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 10155674 — intervention group
Group type: EXPERIMENTAL
Intervention: Late rescue surfactant therapy
Number of subjects: 1000
Study 10155674 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose treatment of severely ill neonates
Number of subjects: 1000
Study 10155674 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-dose treatments
Number of subjects: 1000
Study 10155674 — intervention group
Group type: EXPERIMENTAL
Intervention: Early treatment surfactant therapy
Number of subjects: 1000
Study 10155674 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylaxis surfactant therapy
Number of subjects: 1000
Study 10155674 — intervention group
Group type: EXPERIMENTAL
Intervention: Introduction of porcine-derived lung surfactant (PLS) therapy
Number of subjects: 1000
Study 10155674 — intervention group
Group type: EXPERIMENTAL
Intervention: PLS therapy
Number of subjects: 1000
Study 10155674 — intervention group
Group type: EXPERIMENTAL
Intervention: Costs for PLS therapy
Number of subjects: 1000
Study 10155674 — intervention group
Group type: COMPARATOR
Intervention: Additional costs of PLS therapy per additional survivor
Number of subjects: 1000
Study 10155674 — intervention group
Group type: EXPERIMENTAL
Intervention: Savings in costs per survivor
Number of subjects: 1000
Study 10155674 — intervention group
Group type: EXPERIMENTAL
Intervention: Savings in costs per nonsurvivor
Number of subjects: 1000
Study 2350628 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose chemotherapy and total lymphoid irradiation with 750 cGy for severe aplastic anemia patients.
Number of subjects: 80
Study 2350628 — intervention group
Group type: COMPARATOR
Intervention: High dose chemotherapy and single dose total body irradiation with 750-850 cGy for leukemia patients.
Number of subjects: 80
Study 2350628 — intervention group
Group type: COMPARATOR
Intervention: High dose chemotherapy and fractionated total body irradiation with 1320 cGy for leukemia patients.
Number of subjects: 80
Study 2350628 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate alone as prophylaxis for graft-versus-host disease in aplastic anemia patients.
Number of subjects: 80
Study 2350628 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate, antithymocyte globulin and prednisone regimen as prophylaxis for graft-versus-host disease in aplastic anemia patients.
Number of subjects: 80
Study 7448109 — intervention group
Group type: COMPARATOR
Intervention: Exercise (work load: 450 kpm/min for females, 600 kpm/min for males on a bicycle ergometer for 3 hours)
Number of subjects: 0
Study 7448109 — intervention group
Group type: COMPARATOR
Intervention: Rest (control condition)
Number of subjects: 0
Study 30259172 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan (TLV)
Number of subjects: 81
Study 30259172 — intervention group
Group type: COMPARATOR
Intervention: Furosemide (FUR)
Number of subjects: 81
Study 28750964 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic Compression (IC)
Number of subjects: 40
Study 28750964 — intervention group
Group type: COMPARATOR
Intervention: Lumbopelvic Manipulation (LPM)
Number of subjects: 40
Study 24934652 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline partner victimization
Number of subjects: 603
Study 24934652 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline non-partner victimization
Number of subjects: 603
Study 24934652 — intervention group
Group type: EXPERIMENTAL
Intervention: Victimization at follow-up
Number of subjects: 603
Study 23350660 — intervention group
Group type: EXPERIMENTAL
Intervention: Video group (watched a 13-min cartoon animation)
Number of subjects: 31
Study 23350660 — intervention group
Group type: COMPARATOR
Intervention: Nonvideo group (did not watch the animation)
Number of subjects: 31
Study 23350660 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (video and nonvideo)
Number of subjects: 31
Study 17261465 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (50 mg)
Number of subjects: 39
Study 17261465 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg)
Number of subjects: 39
Study 15037412 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg of rosiglitazone daily for 3 months
Number of subjects: 24
Study 10907386 — intervention group
Group type: EXPERIMENTAL
Intervention: Cloth towels accessed by a rotary dispenser
Number of subjects: 100
Study 10907386 — intervention group
Group type: EXPERIMENTAL
Intervention: Paper towels from a stack on the hand-washing sink
Number of subjects: 100
Study 10907386 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm forced air from a mechanical hand-activated dryer
Number of subjects: 100
Study 10907386 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous room air evaporation
Number of subjects: 100
Study 9116212 — intervention group
Group type: EXPERIMENTAL
Intervention: Event-related potentials (ERPs) recorded during memory source monitoring tasks
Number of subjects: 0
Study 1640395 — intervention group
Group type: EXPERIMENTAL
Intervention: High psychopathology patients
Number of subjects: 1020
Study 1640395 — intervention group
Group type: COMPARATOR
Intervention: Low psychopathology patients
Number of subjects: 1020
Study 3551675 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural pethidine 25 mg
Number of subjects: 200
Study 3551675 — intervention group
Group type: COMPARATOR
Intervention: Epidural saline
Number of subjects: 200
Study 31367733 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined program of textured lunch gatherings with oral and physical exercises (12-week program, twice a week)
Number of subjects: 86
Study 31367733 — intervention group
Group type: COMPARATOR
Intervention: Control group performing physical exercise regimen only
Number of subjects: 86
Study 28422460 — intervention group
Group type: EXPERIMENTAL
Intervention: Philips Sonicare FlexCare Platinum with Premium plaque control brush head (PC)
Number of subjects: 143
Study 28422460 — intervention group
Group type: COMPARATOR
Intervention: ADA Reference manual toothbrush (MTB)
Number of subjects: 143
Study 25544263 — intervention group
Group type: EXPERIMENTAL
Intervention: sugammadex 2 mg/kg
Number of subjects: 100
Study 25544263 — intervention group
Group type: COMPARATOR
Intervention: neostigmine (70 μg/kg) and atropine (0.4 mg per mg neostigmine)
Number of subjects: 100
Study 24085261 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP3A4 inhibitor (ketoconazole 400 mg daily for 10 days)
Number of subjects: 3
Study 24085261 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP3A4 inducer (rifampicin 600 mg daily for 14 days)
Number of subjects: 3
Study 24085261 — intervention group
Group type: EXPERIMENTAL
Intervention: Midostaurin (single dose 100 mg and multiple doses 50 mg twice daily)
Number of subjects: 3
Study 21392603 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 110
Study 21392603 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (intravenous immunoglobulin and aspirin)
Number of subjects: 110
Study 19207622 — intervention group
Group type: EXPERIMENTAL
Intervention: Creative expression workshops (experimental group)
Number of subjects: 105
Study 19207622 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 105
Study 16934470 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual Carbon Fiber Spring AFO (CFO)
Number of subjects: 15
Study 16934470 — intervention group
Group type: EXPERIMENTAL
Intervention: common posterior leaf‐spring (PLS)
Number of subjects: 15
Study 16934470 — intervention group
Group type: COMPARATOR
Intervention: barefoot walking
Number of subjects: 15
Study 16934470 — intervention group
Group type: COMPARATOR
Intervention: shoes without AFO
Number of subjects: 15
Study 15326145 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin-containing ocular gelling minitablets
Number of subjects: 6
Study 15326145 — intervention group
Group type: COMPARATOR
Intervention: Eye drop
Number of subjects: 6
Study 11241570 — intervention group
Group type: EXPERIMENTAL
Intervention: Kaplan-Meier method
Number of subjects: 0
Study 11241570 — intervention group
Group type: EXPERIMENTAL
Intervention: Cause-specific cumulative incidence rates (conventional method)
Number of subjects: 0
Study 11241570 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Cox method
Number of subjects: 0
Study 11241570 — intervention group
Group type: EXPERIMENTAL
Intervention: Cause-specific cumulative incidence rates (Kaplan-Meier estimates)
Number of subjects: 0
Study 9068334 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular tenoxicam 20 mg
Number of subjects: 63
Study 9068334 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular bupivacaine 0.25%
Number of subjects: 63
Study 9068334 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 63
Study 8376613 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 59
Study 8376613 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonazepam
Number of subjects: 59
Study 8376613 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 3740174 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% fluorometholone
Number of subjects: 14
Study 3740174 — intervention group
Group type: COMPARATOR
Intervention: 0.1% dexamethasone sodium phosphate
Number of subjects: 14
Study 29335773 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergomotor (EM) intervention
Number of subjects: 101
Study 29335773 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy (CO)
Number of subjects: 101
Study 27784021 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab treatment (monthly or individualized dosing)
Number of subjects: 1631
Study 27784021 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab treatment (delayed responders)
Number of subjects: 1631
Study 27784021 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline visual acuity (VA)
Number of subjects: 1631
Study 24888911 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Foley catheter and low-dose vaginal misoprostol
Number of subjects: 126
Study 24888911 — intervention group
Group type: COMPARATOR
Intervention: Low-dose vaginal misoprostol alone
Number of subjects: 126
Study 22317753 — intervention group
Group type: EXPERIMENTAL
Intervention: Grief and Trauma Intervention with coping skills and trauma narrative processing (GTI-CN)
Number of subjects: 70
Study 22317753 — intervention group
Group type: COMPARATOR
Intervention: Grief and Trauma Intervention with coping skills only (GTI-C)
Number of subjects: 70
Study 19782352 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 10
Study 19782352 — intervention group
Group type: COMPARATOR
Intervention: Ghrelin (1 microg/kg)
Number of subjects: 10
Study 19782352 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 18654870 — intervention group
Group type: EXPERIMENTAL
Intervention: Undiluted smallpox vaccine
Number of subjects: 104
Study 18654870 — intervention group
Group type: COMPARATOR
Intervention: Threefold diluted smallpox vaccine
Number of subjects: 104